SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Patrizio Mazza, Carla Minoia, Angela Melpignano, Giuseppe Polimeno, Nicola Cascavilla, Nicola Di Renzo, Giorgina Specchia, The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a “real life” retrospective multicenter experience of the Rete Ematologica Pugliese (REP), Annals of Hematology, 2016, 95, 2, 239

    CrossRef

  2. 2
    Yeo-Kyeoung Kim, Seung-Sin Lee, Sung-Hoon Jeong, Jae-Sook Ahn, Deok-Hwan Yang, Je-Jung Lee, Hyeoung-Joon Kim, Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia, Blood Research, 2015, 50, 1, 19

    CrossRef

  3. 3
    Charlotte K. Brierley, David P. Steensma, Thrombopoiesis-stimulating agents and myelodysplastic syndromes, British Journal of Haematology, 2015, 169, 3
  4. 4
    Francesco Rodeghiero, Marco Ruggeri, Treatment of Immune Thrombocytopenia in Adults: The Role of Thrombopoietin-Receptor Agonists, Seminars in Hematology, 2015, 52, 1, 16

    CrossRef

  5. 5
    Guillaume Moulis, Haleh Bagheri, Laurent Sailler, Annie-Pierre Jonville-Bera, Emmanuelle Weber, Claire Guy, Nadine Petitpain, Marie-Laure Laroche, Sylvie Favrelière, Johana Béné, Bernadette Baldin, Laure Villeval-Federici, Martine Tebacher-Alt, Virginie Bres, Gwenaëlle Veyrac, Aurélie Grandvuillemin, Cédric Mauprivez, Maryse Lapeyre-Mestre, Jean-Louis Montastruc, Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009–2013 French PharmacoVigilance assessment, European Journal of Internal Medicine, 2014, 25, 8, 777

    CrossRef

  6. 6
    C. E. Neunert, Current management of immune thrombocytopenia, Hematology, 2013, 2013, 1, 276

    CrossRef